M. Y. Koker Et Al. , "New alpha IIb beta 3 variants in 28 Turkish Glanzmann patients; Structural hypothesis for complex activation by residues variations in I-EGF domains," PLATELETS , vol.33, no.4, pp.551-561, 2022
Koker, M. Y. Et Al. 2022. New alpha IIb beta 3 variants in 28 Turkish Glanzmann patients; Structural hypothesis for complex activation by residues variations in I-EGF domains. PLATELETS , vol.33, no.4 , 551-561.
Koker, M. Y., Sarper, N., Albayrak, C., Zulfikar, B., Zengin, E., Saraymen, B., ... Albayrak, D.(2022). New alpha IIb beta 3 variants in 28 Turkish Glanzmann patients; Structural hypothesis for complex activation by residues variations in I-EGF domains. PLATELETS , vol.33, no.4, 551-561.
Koker, MUSTAFA Et Al. "New alpha IIb beta 3 variants in 28 Turkish Glanzmann patients; Structural hypothesis for complex activation by residues variations in I-EGF domains," PLATELETS , vol.33, no.4, 551-561, 2022
Koker, MUSTAFA Y. Et Al. "New alpha IIb beta 3 variants in 28 Turkish Glanzmann patients; Structural hypothesis for complex activation by residues variations in I-EGF domains." PLATELETS , vol.33, no.4, pp.551-561, 2022
Koker, M. Y. Et Al. (2022) . "New alpha IIb beta 3 variants in 28 Turkish Glanzmann patients; Structural hypothesis for complex activation by residues variations in I-EGF domains." PLATELETS , vol.33, no.4, pp.551-561.
@article{article, author={MUSTAFA YAVUZ KÖKER Et Al. }, title={New alpha IIb beta 3 variants in 28 Turkish Glanzmann patients; Structural hypothesis for complex activation by residues variations in I-EGF domains}, journal={PLATELETS}, year=2022, pages={551-561} }